Pyxis Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pyxis Oncology and other ETFs, options, and stocks.About PYXS
Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
CEOLara S. Sullivan
CEOLara S. Sullivan
Employees44
Employees44
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2018
Founded2018
Employees44
Employees44
PYXS Key Statistics
Market cap209.83M
Market cap209.83M
Price-Earnings ratio-2.51
Price-Earnings ratio-2.51
Dividend yield—
Dividend yield—
Average volume481.76K
Average volume481.76K
High today$4.03
High today$4.03
Low today$3.35
Low today$3.35
Open price$4.01
Open price$4.01
Volume844.48K
Volume844.48K
52 Week high$5.55
52 Week high$5.55
52 Week low$0.8332
52 Week low$0.8332
Stock Snapshot
With a market cap of 209.83M, Pyxis Oncology(PYXS) trades at $3.37. The stock has a price-to-earnings ratio of -2.51.
On 2025-12-17, Pyxis Oncology(PYXS) stock traded between a low of $3.35 and a high of $4.03. Shares are currently priced at $3.37, which is +0.6% above the low and -16.4% below the high.
The Pyxis Oncology(PYXS)'s current trading volume is 844.48K, compared to an average daily volume of 481.76K.
In the last year, Pyxis Oncology(PYXS) shares hit a 52-week high of $5.55 and a 52-week low of $0.83.
In the last year, Pyxis Oncology(PYXS) shares hit a 52-week high of $5.55 and a 52-week low of $0.83.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own PYXS. This list is generated using Robinhood data, and it’s not a recommendation.